Examinant per Autoria "Cornely, Oliver A."
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials(Elsevier, 2024) Thompson, George R.; Soriano, Alex; Honore, Patrick M.; Bassetti, Matteo; Cornely, Oliver A.; Kollef, Marin; Kullberg, Bart Jan; Pullman, John; Hites, Maya; Fortún, Jesús; Horcajada Gallego, Juan Pablo; Kotanidou, Anastasia; Das, Anita F.; Sandison, Taylor; Aram, Jalal A.; Vazquez, Jose A.; Pappas, Peter G.
Ítem Accés Obert Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres(Oxford University Press, 2024) Rutz, Jule; Naendrup, Jan-Hendrik; Bruns, Caroline, 1984-; Classen, Annika Y.; Salmanton-García, Jon; Seifert, Harald; Sprute, Rosanne; Stemler, Jannik; Walker, Sarah V.; Cornely, Oliver A.; Liss, Blasius J.; Mellinghoff, Sibylle C.; SALT study group
Ítem Accés Obert Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study(Oxford University Press, 2020) Cornely, Oliver A.; Cisneros, José M.; Torre-Cisneros, Julian; Rodríguez-Hernández, María Jesús; Tallón-Aguilar, Luis; Calbo, Esther; Horcajada Gallego, Juan Pablo; Queckenberg, Christian; Zettelmeyer, Ulrike; Arenz, Dorothee; Rosso-Fernández, Clara M.; Jiménez-Jorge, Silvia; Turner, Guy; Raber, Susan; O'Brien, Seamus; Luckey, Alison; COMBACTE-CARE consortium/REJUVENATE Study Group